Claire Driscoll
About Claire Driscoll
Claire Driscoll serves as the Director of the NHGRI Technology Transfer Office at the National Human Genome Research Institute, where she has worked since 1999. She possesses extensive expertise in patent management and intellectual property education, and she leads a team focused on licensing genomic technologies.
Work at National Institutes of Health
Claire Driscoll has served as the Director of the NHGRI Technology Transfer Office at the National Human Genome Research Institute, part of the National Institutes of Health, since 1999. In this role, she has been responsible for managing a patent portfolio and making critical decisions regarding pending patent applications. Driscoll represents NHGRI at various conferences, acting as a lead negotiator and decision-maker for transactional agreements. Her work involves marketing genomic technologies available for licensing to biotech and pharmaceutical companies.
Education and Expertise
Claire Driscoll holds a Bachelor of Science degree in Biology from the University of Notre Dame. She furthered her education by obtaining two Master of Science degrees: one in Biological Sciences from the University of Notre Dame and another in Biotechnology Studies from the University of Maryland Global Campus. Her educational background provides a strong foundation for her extensive experience in intellectual property law and technology transfer.
Background
Driscoll has been with the NHGRI for 25 years, contributing significantly to the field of technology transfer in genomics. She manages a team that includes four patent and licensing professionals, administrative support staff, and interns. Her leadership role involves advising Institute leadership on matters related to intellectual property and technology transfer policy, ensuring that NHGRI's innovations are effectively translated into practical applications.
Achievements in Technology Transfer
In her capacity as Director, Claire Driscoll has played a pivotal role in educating NHGRI scientists about intellectual property law and the advantages of collaborating with industry partners. Her efforts in managing the patent portfolio and negotiating agreements have facilitated the successful licensing of genomic technologies, contributing to advancements in the biotech and pharmaceutical sectors.